Assassin’s Creed Shadows is set to launch on February 14, 2024 across Windows PC (via the Ubisoft Store), Xbox Series X|S, PlayStation 5, and Amazon Luna.
The CEO of Ubisoft Yves Guillemot recently made a statement claiming that Ubisoft isn’t trying to push an agenda.
The statement comes after months of blowback from critical fans following the announcement of Assassin’s Creed Shadows. Fans are critical of Yasuke, an enigmatic historical figure being included as the protagonist while also claiming that Ubisoft strives for a degree of historical accuracy.
Critics of the game claim that Yasuke’s historical importance is overstated in order to promote an agenda, while the game’s defenders believe that the complaints are founded in racism.
Here’s the full statement provided by Gamesradar+:
“Let me address some of the polarized comments around Ubisoft lately, I want to reaffirm that we are an entertainment-first company, creating games for the broadest possible audience, and our goal is not to push any specific agenda. We remain committed to creating games for fans and players that everyone can enjoy.”
While it’s unclear whether or not Guillemot meant this in response to the Assassins Creed Shadows criticism, the timing of this statement comes immediately after Ubisoft decided to push the game back to February of next year.
Assassin’s Creed Shadows is set to launch on February 14, 2024 across Windows PC (via the Ubisoft Store), Xbox Series X|S, PlayStation 5, and Amazon Luna.
The Top 20 Motivational Instagram Accounts to Follow (2024)
Bangladeshi police agents accused of selling citizens’ personal information on Telegram
Don’t Waste Your Time in Anger, Regrets, Worries and Grudges
Our new fixed tours are your ultimate Aussie & Kiwi adventure!
Democrats and allies to flood airwaves, drop more than $125M on abortion push
Family Holiday Checklist | What To Pack Family Holiday
Turkish Airlines carries 7.2 mn passengers in May, launches new sustainability brand, BA
Concord price, beta, preorder details for PS5 and PC confirmed